Crescent Biopharma (C68.F) Q2 2026 Earnings

Apr 29Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-4.47
-3.18
-1.89
-0.6

Details

Expected EPS
-0.75230277588
Actual EPS
-0.599396
Surprise EPS
0.15
Surprise Percent
+20.33%

Description

⁨Crescent Biopharma⁩ (⁦C68.F⁩) has reported earnings of ⁦-0.599396⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts